共 62 条
Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders
被引:8
作者:
Venugopal, Abhilash
[1
]
Chaerkady, Raghothama
[1
,2
,3
,4
,5
]
Pandey, Akhilesh
[2
,3
,4
,5
]
机构:
[1] Inst Bioinformat, Bangalore 560066, Karnataka, India
[2] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA
关键词:
Biomarkers;
diagnosis;
isotope labeling;
mass spectrometry;
HUMAN CEREBROSPINAL-FLUID;
ALZHEIMERS-DISEASE;
QUANTITATIVE PROTEOMICS;
AMINO-ACIDS;
PROTEIN BIOMARKERS;
POTASSIUM CHANNEL;
PLASMA-PROTEOME;
IDENTIFICATION;
EXPRESSION;
SERUM;
D O I:
10.4103/0972-2327.48845
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
Mass spectrometry-based quantitative proteomics has emerged as a powerful approach that has the potential to accelerate biomarker discovery, both for diagnostic as well as therapeutic purposes. Proteomics has traditionally been synonymous with 2D gels but is increasingly shifting to the use of gel-free systems and liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Quantitative proteomic approaches have already been applied to investigate various neurological disorders, especially in the context of identifying biomarkers from cerebrospinal fluid and serum. This review highlights the scope of different applications of quantitative proteomics in understanding neurological disorders with special emphasis on biomarker discovery.
引用
收藏
页码:3 / 11
页数:9
相关论文